AU2001282653A1 - Anti-cancer agents comprising disintegrin genes and the treating methods - Google Patents

Anti-cancer agents comprising disintegrin genes and the treating methods

Info

Publication number
AU2001282653A1
AU2001282653A1 AU2001282653A AU2001282653A AU2001282653A1 AU 2001282653 A1 AU2001282653 A1 AU 2001282653A1 AU 2001282653 A AU2001282653 A AU 2001282653A AU 2001282653 A AU2001282653 A AU 2001282653A AU 2001282653 A1 AU2001282653 A1 AU 2001282653A1
Authority
AU
Australia
Prior art keywords
disintegrin
genes
cancer agents
treating methods
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001282653A
Inventor
Kwang-Hoe Chung
Sung-Yu Hong
Chin-Kyu Hun
Yang-Soo Jang
Doo-Sik Kim
Soo-In Kim
Yong-Serk Park
Young-Doug Sohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001282653A1 publication Critical patent/AU2001282653A1/en
Abandoned legal-status Critical Current

Links

AU2001282653A 2001-08-29 Anti-cancer agents comprising disintegrin genes and the treating methods Abandoned AU2001282653A1 (en)

Publications (1)

Publication Number Publication Date
AU2001282653A1 true AU2001282653A1 (en) 2003-03-10

Family

ID=

Similar Documents

Publication Publication Date Title
AU5091201A (en) Vegf-modulated genes and methods employing them
GB0111872D0 (en) Therapeutic agents and methods
HK1053750A1 (en) Jack;jack assembly; and methods
AU2002349784A1 (en) Nf-kappab activating genes
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2003261100A1 (en) Devices delivering therapeutic agents and methods regarding the same
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002352799A1 (en) Methods for evaluating drug-resistance gene expression in the cancer patient
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU2002329759A1 (en) Methyltransferase genes and uses thereof
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU2001222215A1 (en) Lumbago treating girdle
AU2002334891A1 (en) Tumor targeted photodiagnostic-phototherapeutic agents
AU2002335667A1 (en) Modified reoviral therapy
AU2002234165A1 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU2001282653A1 (en) Anti-cancer agents comprising disintegrin genes and the treating methods
AU2002256556A1 (en) Sea-trosy and related methods
AU2001282349A1 (en) Fluid treatment
AU2002328383A1 (en) Equipment for treating painful points in the organism
AU2002329176A1 (en) Targeted particles and methods of using the same
AU2002953516A0 (en) Genetic therapy and genetic modification
AU2002319200A1 (en) Vector and the use thereof in gene therapy methods
AU2002356285A1 (en) Selective anesthetic agents and methods of identifying the same
GB9923381D0 (en) The uses of cell-specific splicing in gene therapy